drugset / Trial / NCT02214602

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

NCT02214602

Phase 4 Completed 240 enrolled Mansoura University
RandomizedParallel-groupSingle-blindPrevention

Summary

The aim of the study is to test the value of immediate post-operative intravesical instillation of epirubicin in patients with intermediate and high risk non muscle invasive bladder cancer (NMIBC).

Timeline

Start
2014-07
Primary completion
2017-04
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Epirubicin Small molecule 50 mg Other